Actively Recruiting
Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)
Led by Centre Paul Strauss · Updated on 2026-01-05
144
Participants Needed
1
Research Sites
473 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a monocentric, comparative, open-label, randomized parallel group study enrolling elderly subjects hospitalized in Strasbourg Europe Cancerology Institute (ICANS), starting chemotherapy or targeted therapy for the treatment of digestive cancer.
CONDITIONS
Official Title
Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must be 63 75 years old
- Performance status 0, 1 or 2
- Diagnosis of digestive cancer, all stages (adjuvant or metastatic), with planned chemotherapy or targeted therapy for 24 weeks or more
- Previous chemotherapy treatment for this digestive cancer allowed
- Estimated life expectancy of at least 3 months
- Ability to speak, read, and understand French
- Signed informed consent
- Social security coverage required
You will not qualify if you...
- History of differentiated neuroendocrine tumors grade 1 or 2 (pancreas, small intestine)
- Current cancer treatment other than hormone therapy for cancers other than digestive cancer
- Major surgery or curative radiation therapy within 4 weeks before study entry
- Inability to comply with medical follow-up due to geographical, social, or psychological reasons
- Patients under guardianship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut de cancérologie Strasbourg Europe
Strasbourg, France, 67033
Actively Recruiting
Research Team
V
Valérie SARTORI
CONTACT
M
Manon VOEGELIN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here